首页> 外文期刊>The Journal of molecular diagnostics: JMD >Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens.
【24h】

Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens.

机译:在福尔马林固定,石蜡包埋的标本中鉴定肿瘤的基于微阵列的基因表达测试的验证和可重复性。

获取原文
获取原文并翻译 | 示例
           

摘要

Tumors whose primary site is challenging to diagnose represent a considerable proportion of new cancer cases. We present validation study results for a gene expression-based diagnostic test (the Pathwork Tissue of Origin Test) that aids in determining the tissue of origin using formalin-fixed, paraffin-embedded (FFPE) specimens. Microarray data files were generated for 462 metastatic, poorly differentiated, or undifferentiated FFPE tumor specimens, all of which had a reference diagnosis. The reference diagnoses were masked, and the microarray data files were analyzed using a 2000-gene classification model. The algorithm quantifies the similarity between RNA expression patterns of the study specimens and the 15 tissues on the test panel. Among the 462 specimens, overall agreement with the reference diagnosis was 89% (95% CI, 85% to 91%). In addition to the positive test results (ie, rule-ins), an average of 12 tissues for each specimen could be ruled out with >99% probability. The large size of this study increases confidence in the test results. A multisite reproducibility study showed 89.3% concordance between laboratories. The Tissue of Origin Test makes the benefits of microarray-based gene expression tests for tumor diagnosis available for use with the most common type of histology specimen (ie, FFPE).
机译:其主要部位难以诊断的肿瘤占新癌症病例的相当大比例。我们提供基于基因表达的诊断测试(Pathwork Tissue of Origin Test)的验证研究结果,该测试有助于使用福尔马林固定,石蜡包埋(FFPE)的标本来确定起源组织。生成了462个转移性,低分化或未分化FFPE肿瘤标本的微阵列数据文件,所有这些均具有参考诊断。掩盖了参考诊断,并使用2000基因分类模型分析了微阵列数据文件。该算法可量化研究样本的RNA表达模式与测试面板上的15种组织之间的相似性。在462个样本中,与参考诊断的总体一致性为89%(95%CI,85%至91%)。除了阳性测试结果(即规则插入)外,每个样本的平均12个组织都可以排除,其可能性大于99%。这项研究的规模很大,可以提高对测试结果的信心。一项多站点可重复性研究显示,实验室之间的一致性为89.3%。组织起源测试使基于微阵列的基因表达测试对肿瘤诊断的优势可用于最常见类型的组织学标本(即FFPE)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号